- Home
- PHVS vs SVM Comparison
PHVS vs SVM Comparison
Compare PHVS & SVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- SVM
- Stock Information
- Founded
- PHVS 2015
- SVM N/A
- Country
- PHVS Switzerland
- SVM Canada
- Employees
- PHVS N/A
- SVM N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- SVM Precious Metals
- Sector
- PHVS Health Care
- SVM Basic Materials
- Exchange
- PHVS Nasdaq
- SVM Nasdaq
- Market Cap
- PHVS 980.3M
- SVM 906.7M
- IPO Year
- PHVS 2021
- SVM N/A
- Fundamental
- Price
- PHVS $18.60
- SVM $4.65
- Analyst Decision
- PHVS Buy
- SVM Strong Buy
- Analyst Count
- PHVS 6
- SVM 1
- Target Price
- PHVS $37.17
- SVM $6.75
- AVG Volume (30 Days)
- PHVS 35.9K
- SVM 7.6M
- Earning Date
- PHVS 08-13-2025
- SVM 08-12-2025
- Dividend Yield
- PHVS N/A
- SVM 0.54%
- EPS Growth
- PHVS N/A
- SVM 40.00
- EPS
- PHVS N/A
- SVM 0.28
- Revenue
- PHVS N/A
- SVM $298,895,000.00
- Revenue This Year
- PHVS N/A
- SVM $1.10
- Revenue Next Year
- PHVS N/A
- SVM $26.47
- P/E Ratio
- PHVS N/A
- SVM $17.42
- Revenue Growth
- PHVS N/A
- SVM 38.90
- 52 Week Low
- PHVS $11.51
- SVM $2.87
- 52 Week High
- PHVS $25.50
- SVM $5.32
- Technical
- Relative Strength Index (RSI)
- PHVS 60.00
- SVM 65.21
- Support Level
- PHVS $16.72
- SVM $4.03
- Resistance Level
- PHVS $17.53
- SVM $4.22
- Average True Range (ATR)
- PHVS 0.93
- SVM 0.17
- MACD
- PHVS 0.07
- SVM 0.03
- Stochastic Oscillator
- PHVS 92.86
- SVM 97.14
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is a mineral exploration company, engaged in the acquisition, exploration, development, and mining of mineral properties. The company's producing mines are located in China, and exploration and development projects are located in China and Ecuador. Its project portfolio comprises the El Domo copper-gold and the Condor gold project in Ecuador. In addition, it operates several silver-lead-zinc mines at the Ying Mining District in Henan Province, China, and the GC silver-lead-zinc mine in Guangdong Province, China. A majority of the company's revenue is generated through the sale of silver concentrates. Its reportable operating segments are the Ying Mining District and GC Mine in China, which derive maximum revenue, and the El Domo and Condor projects in Ecuador.